Postoperative and amputation-free survival outcomes after femorodistal bypass grafting surgery: Findings from the Department of Veterans Affairs National Surgical Quality Improvement Program

Abstract

Risk indices derived from the preoperative workup may be of use to clinicians in assessing and communicating risk and prognosis. Risk-adjustment of outcomes is critical for evaluating future disease management initiatives for patients with advanced peripheral arterial disease.

The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery

“…Neither statin therapy, nor beta-blocker therapy, was found to be associated with statistically significant reductions in perioperative mortality, likely due to a low total mortality (2.5%) in our cohort. This perioperative mortality is consistent with previous studies of patients undergoing peripheral vascular bypass surgery [15]. In the study by Poldermans et al, only 11% of patients had lower extremity revascularization and 38% had acute abdominal aortic surgery.…”

“…It is also striking that PAD patients who require intervention generally do not die as a result of the operation, but have a very high CV mortality in the subsequent year [15]. While this finding is not surprising, our study represents the first in which statin therapy has been associated with improved long-term survival in patients undergoing peripheral vascular surgery.…”

Uninsured South Florida vascular surgery patients are less likely to receive optimal medical management than their insured counterparts

“…Even after surgical interventions, almost half of PAD patients die within a median of 44 months' follow-up, mostly from cardiovascular causes. 3 In fact, a higher mortality rate is prevalent amongst patients with PAD than patients with angina. 4 Furthermore, 30% of ischemic strokes are caused by carotid artery atherosclerosis, adding an even higher direct and indirect burden to our health costs.…”

Popliteo–pedal bypass surgery for critical limb ischemia

“…The study's major amputation free survival rate (54.2, 54.2 and 21.3% at 1-, 3-, 5-years) compared similarly with other large distal bypass studies (74, 56 and 29%) [25].…”